Methods for modulating T cell survival by modulating BCL-XL protein level

Details for Australian Patent Application No. 2003254769 (hide)

Owner Arch Development Corporation United States of America, as represented by the Secretary of the Navy

Inventors June, Carl H.; Thompson, Craig B.

Agent FB Rice

Pub. Number AU-B-2003254769

Parent 764682

Filing date 17 October 2003

Wipo publication date 13 November 2003

Acceptance publication date 29 March 2007

International Classifications

C12N 15/12 (2006.01) Mutation or genetic engineering - Genes encoding animal proteins

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

Event Publications

30 October 2003 Complete Application Filed

13 November 2003 Application Open to Public Inspection

  Published as AU-B-2003254769

10 August 2006 Amendment Made

  The nature of the amendment is: Add co-inventors June, Carl H and Thompson, Craig B

29 March 2007 Application Accepted

  Published as AU-B-2003254769

2 August 2007 Standard Patent Sealed

1 December 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003254770-Identity-coded surface with coded marks

2003254768-Mark-coded surface with function flags